Hyperion Therapeutics To Present At The Leerink Swann Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Feb. 8, 2013 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to present at the Leerink Swann Global Healthcare Conference on Thursday, February 14 at 3:00 p.m. ET (12:00 p.m. PT).

Donald J. Santel, Chief Executive Officer of Hyperion, will provide a company overview. To access the live webcast and subsequent archived recording, please visit Hyperion's website at http://investors.hyperiontx.com/events.cfm .

About Hyperion Therapeutics

Hyperion Therapeutics, Inc. is a commercial stage biopharmaceutical company committed to developing and delivering life-changing treatments for orphan diseases and hepatology. For more information, please visit www.hyperiontx.com
CONTACT: Shari Annes, Investor Relations         (650) 888-0902         sannes@annesassociates.com                  Kristie Kuhl, Media Relations         (203) 556-7417         kkuhl@makovsky.com

If you liked this article you might like

Ireland’s Horizon Pharma Makes $3 Billion Hostile Bid for Depomed

Big Pharma Merger Monday Deals Disregard Biotech Bubble Talks

Stock Markets Soar on Trifecta of Good News

Energy Sector Leads Stock Markets Higher as Rally Rolls On

Teva Buys Tourette Syndrome Drug Firm Auspex for $3.2 Billion